Wall Street analyst estimates for Apollomics, Inc. (APLM): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-09-24 | |||
| 2026-04-27 | $3.80 | ||
| 2025-12-22 | |||
| 2025-07-03 | $-11.37 | ||
| 2025-04-03 | $-16.92 | ||
| 2024-08-14 | $-37.56 | ||
| 2024-03-28 | $-24.00 | $-0.16 | -14900.0% |
| 2023-09-28 | $-2.55 | $-0.00 | -159275.0% |
Valuation Ratios
| Price / Book | -2.92 |
| EV / EBITDA | -6.10 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | $1.8M | $2000 | $323000 | $821000 | $198000 | $8.5M |
| Cost of Revenue | $369000 | 0 | 0 | 0 | 0 | 0 | $255000 |
| Gross Profit | -$369000 | $1.8M | $2000 | $323000 | $821000 | $198000 | $8.2M |
| Research & Development | $18.4M | $31.4M | $35.6M | $35.5M | $34.2M | $24.6M | $5.5M |
| Selling, General & Admin | $5.9M | $11.0M | $15.3M | $9.9M | $20.6M | $17.8M | $12.4M |
| Operating Expenses | $24.4M | $42.5M | $50.9M | $45.4M | $54.8M | $42.3M | $17.7M |
| Operating Income | -$24.7M | -$40.6M | -$50.9M | -$45.1M | -$54.0M | -$42.1M | -$9.5M |
| EBITDA | -$45.3M | -$40.5M | -$50.1M | -$43.9M | -$53.4M | -$41.1M | -$9.2M |
| Interest Expense | $46000 | $72000 | $83000 | $93000 | $150000 | $179000 | $65000 |
| Pre-tax Income | -$45.8M | -$74.9M | -$94.8M | -$240.8M | -$172.6M | -$53.6M | -$10.9M |
| Income Tax | $153000 | -$85000 | $1000 | $1000 | $10000 | $259000 | $3000 |
| Net Income | -$45.9M | -$74.8M | -$94.8M | -$240.8M | -$172.6M | -$53.9M | -$10.9M |
| EPS | $-0.53 | $-20.70 | $-23.45 | $-61.60 | $-231.99 | $-52.80 | $-7.57 |
| EPS (Diluted) | $-0.53 | $-20.70 | $-23.45 | $-61.60 | $-231.99 | $-52.80 | $-7.57 |
| Shares Outstanding (Diluted) | $867958 | $867958 | $867958 | $867958 | $743970 | $926474 | $1.4M |
Price
| Price | $22.11 |
| Market Cap | $49M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ADAP · ANL · ATHA · BLRX · GOVX · ICU · LNAI
Explore sector: Healthcare · Biotechnology
More sections of APLM: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks